Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.24 USD | -2.53% | -10.58% | -34.46% |
05:45pm | UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating | MT |
05-09 | Amicus Therapeutics' Q1 Net Loss Narrows, Net Product Sales Rise | MT |